Proton therapy dose distribution comparison between Monte Carlo and a treatment planning system for pediatric patients with ependymomaa)
- 19 July 2012
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 39 (8) , 4742-4747
Abstract
Purpose : Compare dose distributions for pediatric patients with ependymoma calculated using a Monte Carlo(MC) system and a clinical treatment planning system (TPS). Methods : Plans from ten pediatric patients with ependymoma treated using double scatter proton therapy were exported from the TPS and calculated in our MC system. A field by field comparison of the distal edge (80% and 20%), distal fall off (80% to 20%), field width (50% to 50%), and penumbra (80% to 20%) were examined. In addition, the target dose for the full plan was compared. Results : For the 32 fields from the 10 patients, the average differences of distal edge at 80% and 20% on central axis between MC and TPS are −1.9 ± 1.7 mm (p < 0.001) and −0.6 ± 2.3 mm (p = 0.13), respectively. Excluding the fields that ranged out in bone or an air cavity, the 80% difference was −0.9 ± 1.7 mm (p = 0.09). The negative value indicates that MC was on average shallower than TPS. The average difference of the 63 field widths of the 10 patients is −0.7 ± 1.0 mm (p < 0.001), negative indicating on average the MC had a smaller field width. On average, the difference in the penumbra was 2.3 ± 2.1 mm (p < 0.001). The average of the mean clinical target volume dose differences is −1.8% (p = 0.001), negative indicating a lower dose for MC. Conclusions : Overall, the MC system and TPS gave similar results for field width, the 20% distal edge, and the target coverage. For the 80% distal edge and lateral penumbra, there was slight disagreement; however, the difference was less than 2 mm and occurred primarily in highly heterogeneous areas. These differences highlight that the TPS dose calculation cannot be automatically regarded as correct.Keywords
This publication has 17 references indexed in Scilit:
- The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributionsPhysics in Medicine & Biology, 2010
- Dose to water versus dose to medium in proton beam therapyPhysics in Medicine & Biology, 2009
- Monte Carlo modelling of the treatment line of the Proton Therapy Center in OrsayPhysics in Medicine & Biology, 2009
- Density heterogeneities and the influence of multiple Coulomb and nuclear scatterings on the Bragg peak distal edge of proton therapy beamsPhysics in Medicine & Biology, 2008
- Assessment of the accuracy of an MCNPX-based Monte Carlo simulation model for predicting three-dimensional absorbed dose distributionsPhysics in Medicine & Biology, 2008
- Report of the AAPM Task Group No. 105: Issues associated with clinical implementation of Monte Carlo‐based photon and electron external beam treatment planningMedical Physics, 2007
- Quantifying lateral tissue heterogeneities in hadron therapyMedical Physics, 2007
- Accurate Monte Carlo simulations for nozzle design, commissioning and quality assurance for a proton radiation therapy facilityMedical Physics, 2004
- A pencil beam algorithm for proton dose calculationsPhysics in Medicine & Biology, 1996
- Degradation of the Bragg peak due to inhomogeneitiesPhysics in Medicine & Biology, 1986